MyAverix Finance
F · Healthcare
OXFORD BIODYNAMICS LS-01 (LMQ)
Diagnostics & Research
OXFORD BIODYNAMICS LS-01 (LMQ) is listed on F in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-30, reported market cap is $7.21M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LMQ
OXFORD BIODYNAMICS LS-01 (LMQ) — FAQ
What is OXFORD BIODYNAMICS LS-01's market cap?
OXFORD BIODYNAMICS LS-01 (LMQ) has a reported market cap of $7.21M (data as of 2026-03-30).
What is LMQ's P/E ratio?
The price-to-earnings (P/E) ratio for OXFORD BIODYNAMICS LS-01 (LMQ) is 18.00 (data as of 2026-03-30).
Does OXFORD BIODYNAMICS LS-01 pay a dividend?
Dividend yield is not available in the current snapshot for OXFORD BIODYNAMICS LS-01 (LMQ). Check the MyAverix Finance app for the latest dividend data.
What sector is OXFORD BIODYNAMICS LS-01 in?
OXFORD BIODYNAMICS LS-01 (LMQ) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is LMQ listed on?
LMQ is listed on F.
What is OXFORD BIODYNAMICS LS-01's net margin?
OXFORD BIODYNAMICS LS-01 (LMQ) reports a net margin of 0.0% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.